Folate deficiency: symptoms, causes and why it matters for methylation

Folate and B12 deficiency share many symptoms because both affect the same red blood cell production pathway. Common symptoms of both include persistent fatigue, weakness, shortness of breath, and pallor associated with megaloblastic anaemia. The key clinical distinction is neurological: B12 deficiency causes peripheral neuropathy, subacute combined degeneration of the spinal cord, and cognitive changes that can be irreversible if untreated. Folate deficiency rarely causes the same degree of neurological damage. However, both can cause mood changes, poor concentration, and mouth ulcers. Because the symptoms overlap so significantly, testing both vitamins together is standard practice, and treating folate without checking B12 first risks masking B12 deficiency while allowing neurological damage to continue.

Yes. Standard serum folate reflects dietary intake over the previous few days and can appear normal even when longer-term folate status is inadequate, particularly in people who have recently improved their diet before a test. More importantly, people with MTHFR C677T homozygous variants can have normal serum folate levels but significantly reduced capacity to convert that folate into the active 5-MTHF form used in the methylation cycle. Functional folate insufficiency shows up most reliably as elevated homocysteine, which reflects whether the methylation cycle is actually working, not just whether folate is present in the blood. Testing both serum folate and homocysteine together, alongside MTHFR genetics, gives a more complete picture than serum folate in isolation.

Homocysteine is an amino acid produced as a byproduct of methionine metabolism. The primary pathway for clearing homocysteine from the blood requires folate (in the form of 5-MTHF) and vitamin B12 to donate a methyl group via methionine synthase, converting homocysteine back to methionine. When folate or B12 is insufficient, or when MTHFR variants slow the production of 5-MTHF, this conversion slows and homocysteine accumulates. Elevated homocysteine is consistently associated with increased cardiovascular risk, cognitive decline, and pregnancy complications. It is often the earliest detectable consequence of folate and B12 insufficiency, appearing before anaemia develops, which makes it a more sensitive marker of functional folate status than serum folate alone.

For people with MTHFR C677T homozygous variants, supplementing with 5-methyltetrahydrofolate (5-MTHF) is generally considered the more direct approach because it bypasses the MTHFR conversion step entirely. Standard folic acid requires conversion through the DHFR and MTHFR enzymes before it can enter the methylation cycle. In people with reduced MTHFR activity, large doses of unconverted folic acid may accumulate as unmetabolised folic acid (UMFA) in the blood. 5-MTHF enters the cycle directly without this intermediary step. That said, the form matters most in the context of supplementing specifically for methylation support; for general dietary intake, folate from food sources does not carry the same concern because it is already processed through normal digestive pathways. DNA methylation testing is the most reliable way to know your MTHFR status before making this decision.

Folate is essential for neural tube closure, which occurs within the first 28 days after conception, typically before a pregnancy is confirmed. Inadequate folate at this stage is associated with neural tube defects including spina bifida and anencephaly. The NHS recommends 400 micrograms of folic acid daily from the point of trying to conceive until 12 weeks of pregnancy. Women with a previous neural tube defect-affected pregnancy are recommended a higher dose of 5 mg daily. Women with MTHFR C677T homozygous variants should discuss with their GP whether 5-MTHF rather than standard folic acid is more appropriate for their genetics. Establishing folate status via a blood test before conception, alongside B12 and homocysteine, allows any deficiency to be corrected before it becomes relevant to foetal development.

Yes. Folate deficiency can contribute to fatigue through mechanisms that precede the development of megaloblastic anaemia. Impaired methylation activity reduces the production of SAMe (S-adenosylmethionine), the body's primary methyl donor, which is involved in neurotransmitter synthesis, mitochondrial function, and cellular energy production. Low folate is associated with reduced serotonin and dopamine methylation in the brain, contributing to low mood, poor concentration, and mental fatigue. These effects can occur at borderline folate levels before full-blown anaemia develops. If you are experiencing persistent fatigue alongside low normal folate and mildly elevated homocysteine, addressing folate and B12 status is a reasonable first step even before an anaemia diagnosis is reached.

Folate is the naturally occurring form of vitamin B9 found in food. Folic acid is the synthetic form used in supplements and food fortification. They differ in how they enter the folate metabolic pathway: dietary folate is processed through the gut wall directly into the circulation, while folic acid requires enzymatic reduction by DHFR before it can be used. For most people, folic acid supplementation works well and has an extensive evidence base for pregnancy outcomes and anaemia prevention. For people with MTHFR variants that reduce conversion efficiency, 5-methyltetrahydrofolate (the active coenzyme form) is an alternative that bypasses the DHFR and MTHFR conversion steps entirely. The key practical point is that the form of supplementation you choose should be informed by your genetic status, not just by what is cheapest or most widely available.

DNA methylation, the attachment of methyl groups to specific sites along the DNA strand, is one of the most precise markers of biological ageing currently available. The methylation cycle depends directly on folate as its primary methyl donor, via the conversion of homocysteine to methionine and the production of SAMe. Inadequate folate supply reduces the availability of methyl groups for DNA methylation, which is associated with aberrant methylation patterns and accelerated epigenetic ageing. Studies have found that people with inadequate folate or B12 status show faster biological ageing on epigenetic clock measures than those with optimal status. Stride's DNA methylation testing measures biological age directly, making it possible to track whether improving folate and methylation status is influencing the rate at which your biology ages over time.

Folate and iron are both absorbed in the jejunum, the first part of the small intestine. Coeliac disease causes immune-mediated damage to the intestinal villi, particularly in this region, which directly impairs the absorption of both nutrients. Combined folate and iron deficiency is one of the most common presentations of undiagnosed coeliac disease in adults, often appearing years before gastrointestinal symptoms become obvious. If folate levels are persistently low despite apparently adequate dietary intake and supplementation, investigating coeliac disease is a logical step. Stride's blood panel includes folate, ferritin, and CRP, which can identify the combined deficiency pattern and the inflammatory signal consistent with active coeliac disease, pointing toward the need for formal coeliac testing via your GP.

For most adults who are not pregnant and do not have an absorption problem or MTHFR variant, adequate folate intake from a varied diet that includes regular leafy greens, legumes, and eggs is achievable. The UK Nutrient Reference Value for folate is 200 micrograms per day, and a diet that includes daily servings of spinach, lentils, or broccoli will typically meet this. The complication is that folate is easily destroyed by heat and lost during food processing, so the amount consumed may be significantly lower than the food data implies. Testing serum folate and homocysteine periodically is the most reliable way to know whether your dietary intake is actually maintaining adequate functional status, rather than estimating from what you believe you are eating.